175 related articles for article (PubMed ID: 26390161)
21. Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside.
Peters AL; van Hezel ME; Juffermans NP; Vlaar AP
Blood Rev; 2015 Jan; 29(1):51-61. PubMed ID: 25277811
[TBL] [Abstract][Full Text] [Related]
22. An approach to prevent the severe adverse events associated with transfusion of FDA-approved blood products.
Valeri CR; Ragno G
Transfus Apher Sci; 2010 Jun; 42(3):223-33. PubMed ID: 20392670
[TBL] [Abstract][Full Text] [Related]
23. Pathophysiology of transfusion-related acute lung injury.
Looney MR; Gilliss BM; Matthay MA
Curr Opin Hematol; 2010 Sep; 17(5):418-23. PubMed ID: 20601870
[TBL] [Abstract][Full Text] [Related]
24. [Transfusion-related acute lung injury].
Tank S; Sputtek A; Kiefmann R
Anaesthesist; 2013 Apr; 62(4):254-60. PubMed ID: 23558721
[TBL] [Abstract][Full Text] [Related]
25. Impact of immunoreactive substances contained in apheresis platelet concentrate on postoperative respiratory function in surgical patients receiving platelet transfusion: a prospective cohort study.
Kanai R; Iijima T; Hashimoto S; Nakazawa H; Ohnishi H; Yorozu T; Ohkawa R; Nojiri T; Shimizu M; Okazaki H
Transfus Med; 2013 Oct; 23(5):344-50. PubMed ID: 23841680
[TBL] [Abstract][Full Text] [Related]
26. Transfusion-related acute lung injury in a neutropenic patient.
Finlayson J; Grey D; Kavanagh L; Witt C
Intern Med J; 2011 Aug; 41(8):638-41. PubMed ID: 21831120
[TBL] [Abstract][Full Text] [Related]
27. Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections.
Williams D; Rao M; Carey P
J Clin Apher; 2012; 27(4):205-11. PubMed ID: 22535678
[TBL] [Abstract][Full Text] [Related]
28. Transfusion-related acute lung injury: a clinical review.
Vlaar AP; Juffermans NP
Lancet; 2013 Sep; 382(9896):984-94. PubMed ID: 23642914
[TBL] [Abstract][Full Text] [Related]
29. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions.
Blumberg N; Heal JM; Gettings KF; Phipps RP; Masel D; Refaai MA; Kirkley SA; Fialkow LB
Transfusion; 2010 Dec; 50(12):2738-44. PubMed ID: 20561296
[TBL] [Abstract][Full Text] [Related]
30. Ten years of TRALI mitigation: measuring our progress.
Vossoughi S; Gorlin J; Kessler DA; Hillyer CD; Van Buren NL; Jimenez A; Shaz BH
Transfusion; 2019 Aug; 59(8):2567-2574. PubMed ID: 31145481
[TBL] [Abstract][Full Text] [Related]
31. Platelet and TRALI: From blood component to organism.
Tariket S; Sut C; Hamzeh-Cognasse H; Laradi S; Garraud O; Cognasse F
Transfus Clin Biol; 2018 Sep; 25(3):204-209. PubMed ID: 29631963
[TBL] [Abstract][Full Text] [Related]
32. Transfusion-related acute lung injury: a preventable syndrome?
Müller MC; Juffermans NP
Expert Rev Hematol; 2012 Feb; 5(1):97-106. PubMed ID: 22272709
[TBL] [Abstract][Full Text] [Related]
33. TRALI risk reduction: donor and component management strategies.
Eder AF; Benjamin RJ
J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
[TBL] [Abstract][Full Text] [Related]
34. Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008.
Ozier Y; Muller JY; Mertes PM; Renaudier P; Aguilon P; Canivet N; Fabrigli P; Rebibo D; Tazerout M; Trophilme C; Willaert B; Caldani C
Transfusion; 2011 Oct; 51(10):2102-10. PubMed ID: 21382042
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Platelet Responses in Transfusion-Related Acute Lung Injury (TRALI).
Zeeuw van der Laan EAN; van der Velden S; Porcelijn L; Semple JW; van der Schoot CE; Kapur R
Transfus Med Rev; 2020 Oct; 34(4):227-233. PubMed ID: 33036839
[TBL] [Abstract][Full Text] [Related]
36. Characterizing the epidemiology of postoperative transfusion-related acute lung injury.
Clifford L; Jia Q; Subramanian A; Yadav H; Wilson GA; Murphy SP; Pathak J; Schroeder DR; Kor DJ
Anesthesiology; 2015 Jan; 122(1):12-20. PubMed ID: 25611652
[TBL] [Abstract][Full Text] [Related]
37. The divergent clinical presentations of transfusion-related acute lung injury illustrated by two case reports.
Vlaar AP; Porcelijn L; van Rooijen-Schreurs IH; Lardy NM; Kersten MJ; Juffermans NP
Med Sci Monit; 2010 Oct; 16(10):CS129-34. PubMed ID: 20885357
[TBL] [Abstract][Full Text] [Related]
38. Transfusion-related acute lung injury in an era of TRALI risk mitigation.
Lavelle JC; Grant ML; Karp JK
Immunohematology; 2015; 31(4):155-8. PubMed ID: 27187195
[TBL] [Abstract][Full Text] [Related]
39. Platelet-neutrophil interactions as a target for prevention and treatment of transfusion-related acute lung injury.
Caudrillier A; Looney MR
Curr Pharm Des; 2012; 18(22):3260-6. PubMed ID: 22621270
[TBL] [Abstract][Full Text] [Related]
40. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine.
Flesch BK; Petershofen EK; Bux J
Tissue Antigens; 2011 Jul; 78(1):1-7. PubMed ID: 21658007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
